Treating Leukemia in the Time of COVID-19

Clicks: 3
ID: 269073
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #23 of 25 articles by views in acta haematologica

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
The coronavirus disease 2019 (COVID-19) pandemic poses several challenges to the management of patients with leukemia. The biology of each leukemia and its corresponding treatment with conventional intensive chemotherapy, with or without targeted therapies ...
Reference Key
jabbouractatreating Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Shilpa Paul, Caitlin R. Rausch, Nitin Jain, Tapan Kadia, Farhad Ravandi, Courtney D. DiNardo, Mary Alma Welch, Bouthaina S. Dabaja, Naval Daver, Guillermo Garcia-Manero, William Wierda, Naveen Pemmaraju, Guillermo Montalban Bravo, Philip Thompson, Srdan Verstovsek, Marina Konopleva, Hagop Kantarjian, Elias Jabbour;Shilpa Paul;Caitlin R. Rausch;Nitin Jain;Tapan Kadia;Farhad Ravandi;Courtney D. DiNardo;Mary Alma Welch;Bouthaina S. Dabaja;Naval Daver;Guillermo Garcia-Manero;William Wierda;Naveen Pemmaraju;Guillermo Montalban Bravo;Philip Thompson;Srdan Verstovsek;Marina Konopleva;Hagop Kantarjian;Elias Jabbour;
Journal acta haematologica
Year Year not found
DOI
10.1159/000508199
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.